drugset / Trial / NCT01336972

Short-term Renal Hemodynamic Effects of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

NCT01336972

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the trial was to determine the short-term effects of tolvaptan in patients with autosomal dominant polycystic kidney disease (ADPKD) at various levels of renal function.

Timeline

Start
2010-10
Primary completion
2011-11
Completion
2011-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tolvaptan Small molecule Oral